B-cell malignancies

Immuneel and Arogya Finance Launch India’s First Zero Cost EMI Programme for Qartemi CAR-T Therapy

Immuneel Therapeutics has announced a strategic partnership with Arogya Finance to launch India’s first Zero Cost EMI programme of up…